Cancer Diagnostics

Turning tissue and liquid biopsies into answers when you need them

ArcherDX is developing a new solid tumor IVD designed to identify actionable genomic alterations in tissue and blood samples that is intended for use as a companion diagnostic.

If approved by the FDA, the assay will be a universal in vitro diagnostic (IVD) that utilizes AMP™ chemistry to measure clinically relevant genomic mutations for tumor profiling and companion diagnostic markers.

 NOT APPROVED BY US FDA.  NOT FOR DIAGNOSTIC USE.  NOT FOR COMMERCIAL DISTRIBUTION.